CVT-301

Randomized Safety Study of CVT-301 Compared to an Observational Control Group

Topic / Pathology

  • Parkinson's Disease

Objectives

To have more informations, click on the link below: 

https://clinicaltrials.gov/ct2/show/record/NCT02352363?term=CVT-301-005&rank=1

Sponsor

Acorda Therapeutics

Scientific publication(s)

  • Grosset DG et al. Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study. Parkinsonism Relat Disord. 2020 Feb;71:4-10.

    https://pubmed.ncbi.nlm.nih.gov/31927343/

Status

Published results

Participating centers

Share

Updated on 17 February 2023